Cargando…
Clinical Usefulness of Hydromorphone-OROS in Improving Sleep Disturbances in Korean Cancer Patients: A Multicenter, Prospective, Open-Label Study
PURPOSE: To evaluate the efficacy of hydromorphone-OROS (HM-OROS) in reducing sleep disturbance and relieving cancer pain. MATERIALS AND METHODS: One hundred twenty cancer patients with pain (numeric rating scale [NRS] ≥ 4) and sleep disturbance (NRS ≥ 4) were evaluated. The initial HM-OROS dosing w...
Autores principales: | Shin, Seong Hoon, Lee, Ho Sup, Kim, Yang Soo, Choi, Young Jin, Kim, Sung Hyun, Kwon, Hyuk Chan, Oh, Sung Yong, Kang, Jung Hun, Sohn, Chang Hak, Lee, Sang Min, Baek, Jin Ho, Min, Young Joo, Kim, Choongrak, Chung, Joo Seop |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Cancer Association
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4206066/ https://www.ncbi.nlm.nih.gov/pubmed/25043822 http://dx.doi.org/10.4143/crt.2013.130 |
Ejemplares similares
-
Once-Daily OROS Hydromorphone for Management of Cancer Pain: an Open-Label, Multi-Center, Non-Interventional Study
por: Park, Cheol Kyu, et al.
Publicado: (2016) -
The protective effect of hydromorphone to ischemia in rat glial cells
por: Kim, Young Sung, et al.
Publicado: (2016) -
A new extended release formulation (OROS(®)) of hydromorphone in the management of pain
por: Weinstein, Sharon M
Publicado: (2009) -
A prospective multicentre study to evaluate the efficacy and tolerability of osmotic release oral system (OROS(®)) hydromorphone in opioid-naive cancer patients: Results of the Korean South West Oncology Group study
por: Song, Eun-Kee, et al.
Publicado: (2015) -
Repeat-dose steady-state pharmacokinetic evaluation of once-daily hydromorphone extended-release (OROS(®) hydromorphone ER) in patients with chronic pain
por: Vandenbossche, Joris, et al.
Publicado: (2012)